UNIVERSITY OF CALIFORNIA, IRVINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1965-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uci.edu
Retapamulin for Reducing MRSA Nasal Carriage
Phase 4
Completed
- Conditions
- Methicillin-Resistant Staphylococcus Aureus
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2018-04-02
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 53
- Registration Number
- NCT01461668
- Locations
- 🇺🇸
University of California, Irivne, Irvine, California, United States
Diagnosis of Pancreatic Cysts: Endoscopic Ultrasound With Fine Needle Aspiration (EUS/FNA), Direct Visualization, and Confocal Laser-induced Endomicroscopy-A Pilot Study
Completed
- Conditions
- Pancreatic Cysts
- First Posted Date
- 2011-10-06
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 104
- Registration Number
- NCT01447238
- Locations
- 🇺🇸
University of California, Irvine Medical Center, Orange, California, United States
Effects of a High Protein Diet on Clinical Outcomes in Heart Failure
Not Applicable
Completed
- Conditions
- Heart FailureDiabetes Mellitus
- Interventions
- Procedure: 12-week supervised weight loss intervention
- First Posted Date
- 2011-08-25
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 78
- Registration Number
- NCT01423266
- Locations
- 🇺🇸
University of California Medical Center, Orange, California, United States
Impact of Exercise on Body Composition in Premature Infants
Not Applicable
Withdrawn
- Conditions
- Body Composition, Beneficial
- Interventions
- Other: Exercise/Social Behavioral
- First Posted Date
- 2011-06-30
- Last Posted Date
- 2021-01-25
- Lead Sponsor
- University of California, Irvine
- Registration Number
- NCT01386190
- Locations
- 🇺🇸
University of California, Irvine Douglas Hospital, Orange, California, United States
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
Recruiting
- Conditions
- Paget Disease of BoneFrontotemporal DementiaInclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal DementiaMyopathy
- First Posted Date
- 2011-05-13
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 50
- Registration Number
- NCT01353430
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
Completed
- Conditions
- PORT WINE STAIN
- Interventions
- Device: Image-guided remove Port Wine Stain
- First Posted Date
- 2011-04-12
- Last Posted Date
- 2022-11-01
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 69
- Registration Number
- NCT01333553
- Locations
- 🇺🇸
Beckman Laser Institute Medical clinic, Irvine, California, United States
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
Phase 2
Completed
- Conditions
- Stage IIIA MelanomaMelanomaMalignant MelanomaStage IIIB MelanomaStage IIIC Melanoma
- Interventions
- Procedure: therapeutic conventional surgeryOther: laboratory biomarker analysisOther: pharmacological study
- First Posted Date
- 2011-03-23
- Last Posted Date
- 2021-01-20
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 11
- Registration Number
- NCT01321437
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus
Early Phase 1
Terminated
- Conditions
- Pemphigus
- Interventions
- First Posted Date
- 2011-03-14
- Last Posted Date
- 2017-06-09
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 3
- Registration Number
- NCT01313923
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging
Withdrawn
- Conditions
- Breast Cancer
- First Posted Date
- 2011-01-14
- Last Posted Date
- 2022-11-01
- Lead Sponsor
- University of California, Irvine
- Registration Number
- NCT01277263
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, UCIMC, Orange, California, United States
🇺🇸Pacific Breast Care Medical Clinic, Costa Mesa, California, United States
🇺🇸Beckman Laser Institute, Irvine, California, United States
Study of Chemotherapy Side Effects in Cancer Patients: Non-invasive Optical Measurements of the Brain
Withdrawn
- Conditions
- Signs and Symptoms
- Interventions
- Device: Diffuse optical spectroscopy and Near infrared spectroscopy
- First Posted Date
- 2011-01-14
- Last Posted Date
- 2022-11-01
- Lead Sponsor
- University of California, Irvine
- Registration Number
- NCT01277276
© Copyright 2025. All Rights Reserved by MedPath